KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Depreciation & Amortization (CF) (2016 - 2025)

Globus Medical (GMED) has disclosed Depreciation & Amortization (CF) for 15 consecutive years, with $69.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 2.1% year-over-year to $69.0 million, compared with a TTM value of $276.8 million through Dec 2025, up 9.26%, and an annual FY2025 reading of $276.8 million, up 9.26% over the prior year.
  • Depreciation & Amortization (CF) was $69.0 million for Q4 2025 at Globus Medical, down from $71.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $72.0 million in Q4 2023 and bottomed at $16.8 million in Q3 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $40.7 million, with a median of $28.3 million recorded in 2021.
  • The sharpest move saw Depreciation & Amortization (CF) dropped 11.52% in 2022, then surged 325.52% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $16.8 million in 2021, then grew by 0.48% to $16.9 million in 2022, then skyrocketed by 325.52% to $72.0 million in 2023, then fell by 6.06% to $67.6 million in 2024, then increased by 2.1% to $69.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for GMED at $69.0 million in Q4 2025, $71.1 million in Q3 2025, and $70.6 million in Q2 2025.